The first DPP-4 inhibitor received marketing authorization in 2006, and now, world-wide, there are currently at least 11 different inhibitors approved for therapy of T2DM (35)
Survodutide (BI 456906) is similar to the active ingredient tirzepatide (Mounjaro, Zepbound) in that it combines two mechanisms of action
Weight loss is rarely a straight line, but with the right tools and a supportive team, it is achievable
Sikiric, P., et al., A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine
Contenu du pack lments du pack Pourquoi choisir lActyl-L-Carnitine